Results 111 to 120 of about 303,454 (271)

MYLK c.4079G>A, p.(Gly1360Asp) Variant Associated With Hereditary Thoracic Aortic Diseases and Early Onset Aortic Dissection

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Aims Thoracic aortic aneurysms and dissections are major causes of sudden cardiovascular death. We aimed to evaluate the clinical significance of the MYLK c.4079G>A, p.(Gly1360Asp) variant in Finnish families with heritable thoracic aortic disease (HTAD) and to assess evidence for a potential founder effect.
Minja Virtanen   +8 more
wiley   +1 more source

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

Spectrum of Congenital Malformations in Sex Chromosome Tetrasomies and Pentasomies: A Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Sex chromosome aneuploidies represent a heterogeneous group of chromosomal conditions, in which phenotypic complexity generally increases with the number of supernumerary sex chromosomes. While Turner syndrome and sex chromosome trisomies are relatively well characterized, less is known about congenital malformations in sex chromosome ...
Anna Colding   +3 more
wiley   +1 more source

Pulmonary Embolism—A Century of Progress

open access: yesANZ Journal of Surgery, EarlyView.
Reviews a century of progress in the diagnosis, prevention, and management of pulmonary embolism; from the first successful surgical embolectomy in 1924 to advanced imaging, pharmacological thromboprophylaxis, and treatment. In the 21st century, advances include catheter‐directed thrombolysis or mechanical thrombectomy under decision‐making guidance of
D. A. Watters
wiley   +1 more source

Tricuspid valve papillary fibroelastoma in an adult patient: a case report and review of literature

open access: yesJournal of Cardiothoracic Surgery
Background Tricuspid valve papillary fibroelastoma is a rare, benign primary cardiac tumor located on the tricuspid valve, with a potential risk of embolism.
Zhenchun Ji   +7 more
doaj   +1 more source

Tricuspid valve disease [PDF]

open access: yesAnnals of Cardiothoracic Surgery, 2017
Christopher, Harris   +2 more
openaire   +2 more sources

Single-session double valve replacement: TAVI+tricuspid valve-in-valve procedures

open access: yes, 2019
We describe a 70-year-old lady with rheumatic heart disease and a history of the mitral valve and tricuspid valve replacement, who underwent transcatheter aortic valve implantation and the tricuspid valve-in-valve procedure in a single session.
Mortazavi, S.H.   +4 more
core  

Isolated tricuspid valve endocarditis

open access: yes, 2009
SummaryWe present two non-HIV-infected patients with isolated native non-rheumatic tricuspid valve endocarditis who were not intravenous drug abusers. The patients presented with fever and chills.
Safari, Hossein   +2 more
core   +1 more source

Continuous‐Flow Left Ventricular Assist Devices in Biventricular Configuration: A Systematic Review and Comparative Meta‐Analysis of HeartMate 3 and HeartWare Biventricular Assist Devices

open access: yesArtificial Organs, EarlyView.
HeartWare‐BiVAD was associated with more frequent right ventricular cannulation, whereas HM3‐BiVAD demonstrated a trend toward improved survival despite a more severe preimplant clinical profile, suggesting a potential device‐related advantage of HM3 in biventricular support.
Daler Rahimov   +10 more
wiley   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy